MedCity News October 4, 2024
Marissa Plescia

Walmart’s Cancer Centers of Excellence program historically focused on some of the most prevalent cancers, such as breast, lung, colon, prostate, pancreatic and blood cancer. Now, employees can access the same benefit for a whole host of other cancers, including bone, pituitary, liver, thyroid, central nervous system and gynecological.

At a time when cancer is one of the top drivers of costs for employers, Walmart is taking action.

The retail giant announced Wednesday that it is expanding its Cancer Centers of Excellence (COE) health benefit to include “virtually any cancer.” A Center of Excellence is a group of people who specialize in a certain area, and Walmart’s Cancer COE is provided to Walmart’s employees and their dependents in partnership with...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Provider, Retailer
Walmart and Amazon Expand AI Investments to Boost Efficiency
Amazon Pledges $26B Quarterly for GenAI and Retail Overhaul
What to expect from healthcare providers and retailers this year
The Year in Amazon vs Walmart, and a Look Into 2025
AI, Omnichannel and Social Commerce: Inside the 2024 D2C Transformation

Share This Article